Table 5.
25(OH)D quartiles and continuous CV risk factors at enrollment*
Unadjusted model |
Adjusted model 1† |
Adjusted model 2‡ |
||||
---|---|---|---|---|---|---|
CV risk factor | β § | 95% CI | β § | 95% CI | β § | 95% CI |
CRP | ||||||
Q2 | −0.12 | −0.48, 0.24 | −0.11 | −0.47, 0.25 | −0.10 | −0.47, 0.26 |
Q3 | −0.30 | −0.66, 0.06 | −0.30 | −0.68, 0.08 | −0.30 | −0.69, 0.08 |
Q4 | −0.38¶ | −0.76, −0.01¶ | −0.44¶ | −0.84, −0.04¶ | −0.44¶ | −0.85, −0.03¶ |
Homocysteine | ||||||
Q2 | 0.10 | −0.04, 0.25 | 0.077 | −0.07, 0.23 | 0.08 | −0.08, 0.23 |
Q3 | −0.02 | −0.16, 0.13 | −0.04 | −0.20, 0.12 | −0.03 | −0.20, 0.13 |
Q4 | −0.01 | −0.16, 0.14 | −0.04 | −0.21, 0.12 | −0.03 | −0.21, 0.14 |
Creatinine | ||||||
Q2 | 0.14 | −0.09, 0.38 | 0.12 | −0.12, 0.36 | 0.13 | −0.11, 0.37 |
Q3 | 0.13 | −0.10, 0.36 | 0.09 | −0.15, 0.32 | 0.10 | −0.15, 0.34 |
Q4 | 0.06 | −0.16, 0.28 | 0.02 | −0.22, 0.25 | 0.03 | −0.21, 0.27 |
SLEDAI-2K | ||||||
Q2 | −1.22¶ | −2.24, −0.20¶ | −1.44¶ | −2.43, −0.46¶ | −1.38¶ | −2.37, −0.38¶ |
Q3 | −1.88¶ | −2.90, −0.86¶ | −2.15¶ | −3.17, −1.12¶ | −2.16¶ | −3.19, −1.12¶ |
Q4 | −2.27¶ | −3.30, −1.25¶ | −2.22¶ | −3.26, −1.18¶ | −2.37¶ | −3.25, −1.31¶ |
25(OH)D = 25-hydroxyvitamin D; CV = cardiovascular; 95% CI = 95% confidence interval; CRP = C-reactive protein; Q = 25(OH)D quartile; SLEDAI-2K = Systemic Lupus Erythematosus Disease Activity Index 2000.
Adjusted model 1: controlled for age, sex, season, white race, and country (Korea, UK, US, or other).
Adjusted model 2: controlled for same as model 1 plus body mass index. When looking at women and men, model controlled for only age, season, white race, and country.
Represents the mean difference in risk factor between Q1 and Q2, Q3, and Q4.
Statistically significant.